HOME >> MEDICINE >> NEWS
OHSU Cancer Institute shows findings of immunotherapy vaccine in prostate cancer patients

PORTLAND, Ore. -- Data from an ongoing study designed to explore the biologic and clinical activity of cancer immunotherapy sipuleucel-T, or Provenge, in patients with early stage recurrent prostate cancer who have a rising serum prostate specific antigen (PSA) level, but who have not yet developed metastatic disease will be presented by Oregon Health & Science University Cancer Institute researchers.

The study showed that sipuleucel-T did not significantly delay the time it took for a patient's PSA to reach a value of 3 ng/ml, the primary endpoint of the study, but it did show a prolongation in prostate-specific antigen doubling time (PSADT). In addition, there was a trend observed in slowing the time to metastatic disease for patients who received sipuleucel-T compared with those who received placebo, but this early trend did not reach statistical significance. The findings will be presented Saturday, June 2, at 8 a.m. (CDT) at the 43rd Annual Meeting of the American Society of Clinical Oncologists (ASCO) in Chicago.

"While there was no delay in the time to PSA recurrence, we did observe a slowing in the rate of rise of serum PSA in exploratory analyses. Additional follow-up is needed to determine if this effect on PSA will translate into patient benefits," said Tomasz Beer, M.D., lead investigator, director of the Prostate Cancer Research program at the OHSU Cancer Institute; and associate professor of medicine, (hematology/medical oncology) OHSU School of Medicine.

The ongoing trial, known as P-11, is a double-blind, multi-center, randomized, placebo-controlled study involving 176 men, all of whom had prostatectomies and then had recurrent cancer as detected by a rise in the serum tumor marker, PSA. After three months of hormone therapy, 117 men received sipuleucel-T and 59 received placebo.

Sipuleucel-T was found to have a favorable safety profile. The most common side effects seen more commonly in sipuleucel-T-t
'"/>

Contact: Christine Decker
deckerch@ohsu.edu
503-494-8231
Oregon Health & Science University
2-Jun-2007


Page: 1 2 3

Related medicine news :

1. American Cancer Society to hold third annual Virtual Relay For Life in Second Life
2. Cancer research summaries
3. Cancer on the agenda of the Portuguese EU Council Presidency
4. Tony Hunter receives Robert. J. and Claire Pasarow Award for Cancer Research
5. OHSU Cancer Institute, VA researchers find way to identify which men need a second biopsy
6. OHSU Cancer Institute researcher identifies protein marker for prostate cancer survival
7. Ireland Cancer Center researcher lays out benefits of aspirin to prevent colon cancer
8. Mayo Clinic Cancer Center researcher finds mold by-product kills multiple myeloma
9. Margaret Foti receives AACR Award for Leadership and Extraordinary Achievements in Cancer Research
10. Cancer-fighting foods, supplements explored in day-long symposium, March 25
11. Cancer vaccine innovator honored with prestigious Florey Medal

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/17/2018)... DIEGO (PRWEB) , ... October 17, 2018 , ... The ... of the California Association of Food Banks at a meeting of its Board of ... member food banks across the State of California. CAFB provides its member food banks ...
(Date:10/17/2018)... ... ... Myers’ have been doing this for five years. This year’s event takes place ... 91326. , “The Harvest Festival is another way we like to give back to our ... LA,” said Kris and Keith. , The event includes a 50/50 raffle, where half ...
(Date:10/16/2018)... COSTA MESA, Calif. (PRWEB) , ... October 16, ... ... financing company that specializes in small business loans, equipment leasing, and franchise ... its franchise owners throughout the United States. Balboa Capital will structure and deliver ...
(Date:10/16/2018)... KENMORE, Wash. (PRWEB) , ... October 16, 2018 ... ... E. Pizzorno was the recipient of the Academy of Integrative Health and Medicine’s ... paradigm dedicated to natural medicine. , Dr. Pizzorno was selected as AIHM’s ...
(Date:10/16/2018)... ... 2018 , ... dicentra Global Certifications, an affiliate of dicentra Cannabis Consulting, has ... become the first G7 country in the world to formally legalize the recreational production ... legalize the production and use of cannabis edibles. , More than one in four ...
Breaking Medicine News(10 mins):
(Date:10/16/2018)... ... 2018 , ... AMGtime will be exhibiting at the LeadingAge ... booth 1940, AMGtime will showcase time, labor management, and scheduling solutions including cloud ... Skilled Nursing Facility module . , Designed to appease common pain points ...
(Date:10/13/2018)... ... 2018 , ... In the aftermath of Hurricane Michael, Visit ... availability for anyone in need, and the Pensacola International Airport is in standard ... aftermath, Pensacola is open and has hotel availability for anyone in need. The ...
(Date:10/13/2018)... ... October 13, 2018 , ... In the world of contract manufacturing, Ion Labs ... another. 2018 has been a game-changing year for Ion Labs . Expansions in ... in the growth. Ion Labs attributes its growth to its responsiveness to customer inquiries, ...
Breaking Medicine Technology:
Cached News: